We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

IOP Lowering Effect of PLT Versus SLT in Naiv OAG Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2013 by University of Zurich.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01886456
First Posted: June 25, 2013
Last Update Posted: June 25, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Zurich
June 21, 2013
June 25, 2013
June 25, 2013
February 2013
February 2017   (Final data collection date for primary outcome measure)
Intraocular pressure 6 months after Intervention [ Time Frame: 6 months ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
IOP Lowering Effect of PLT Versus SLT in Naiv OAG Patients
Effect of Patterned Laser Trabeculoplasty on Intraocular Pressure Compared to Selective Laser Trabeculoplasty in Treatment Naiv Patients Suffering From Open-angle Glaucoma or Ocular Hypertension

To investigate the effect of patterned laser trabeculoplasty (PLT) compared to selective laser trabeculoplasty (SLT) on intraocular pressure (IOP) in treatment naiv patients suffering from open-angle glaucoma or ocular hypertension.

Values for IOP will be measured at baseline, 1 day and 1 month post-interventional as well as 2, 3, 6, 9, 12, 18 and 24 months after treatment.

  • Trial with medical device
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Open Angle Glaucoma,
  • Ocular Hypertension
Device: Laser trabeculoplasty
  • Experimental: PLT
    patients treated with patterned laser trabeculoplasty
    Intervention: Device: Laser trabeculoplasty
  • Active Comparator: SLT
    patients treated with selective laser trabeculoplasty
    Intervention: Device: Laser trabeculoplasty
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
210
February 2017
February 2017   (Final data collection date for primary outcome measure)

Inclusion criteria:

  • Intraocular pressure (treatment naiv or after 4 weeks wash-out phase) > 21 mm Hg
  • visible angle structures over 360° on gonioscopy
  • age = 18 years

Exclusion criteria:

  • Intraocular Inflammation
  • patients who underwent refractive corneal surgery for any reason or who underwent ocular surgery to reduce intraocular pressure (e.g. trabeculectomy)
  • monocle situation
  • anterior chamber lenses (incl. iris claw)
  • secondary glaucoma (with the exception of pseudoexfoliation and pigment dispersion)
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
 
NCT01886456
14.1.2013_KEK ZH 2012-0422
Not Provided
Not Provided
Not Provided
University of Zurich
University of Zurich
Not Provided
Principal Investigator: Christoph Kniestedt, MD University Hospital Zurich, Ophthalmology Clinic
University of Zurich
June 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP